Wait-and-see policy versus loop excision after two consecutive pap 2 cervical smears: Fewer interventions and an equivalent outcome over time; no real contribution to be expected from high-risk human papillomavirus detection;Expectatief beleid versus lisexcisies na 2 opeenvolgende pap-2-uitstrijkjes: Op termijn minder ingrepen en een gelijke uitkomst; geen wezenlijke bijdrage te verwachten van detectie van hoogrisico-humaanpapillomavirus

Nederlands Tijdschrift voor Geneeskunde

Volumn 147, Issue 7, 2003, Pages 302-306

  Bekkers, R L M ^a   Hanselaar, A G J M ^a   Melchers, W J G ^a,b   Van Schaik, J H M ^a   Boonstra, H ^a   Massuger, L F A G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COLPOSCOPY; CONTROLLED STUDY; CYTODIAGNOSIS; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; TREATMENT PLANNING; UTERINE CERVIX CARCINOMA IN SITU; VAGINITIS; VIRUS DETECTION; WART VIRUS;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; COHORT STUDIES; COLPOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIAGE; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0037442406     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Baldauf JJ, Ritter J. Comparison of the risks of cytologic surveillance of women with atypical cells or low-grade abnormalities on cervical smear: review of the literature. Eur J Obstet Gynecol Reprod Biol 1998;76:193-9.
2. Melnikow J, Nuovo J, Willan AR, Chan BKS, Howell LP. Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 1998;92(4 Pt 2):727-35.
3. Morin C, Bairati I, Bouchard C, Fortier M, Roy M, Moore L, et al. Managing atypical squamous cells of undetermined significance in Papanicolaou smears. J Reprod Med 2001;46:799-805.
4. Giard RWM, Hermans J, Doornewaard H. Landelijke resultaten van cervixcytologische diagnostiek in 1992; de screening kan doelmatiger. Ned Tijdschr Geneeskd 1994;138:1325-30.
5. Hanselaar AGJM. Test op humaan papillomavirus: voorlopig geen meerwaarde voor het al verbeterde bevolkingsonderzoek naar baarmoederhalskanker. Ned Tijdschr Geneeskd 2000;144:1668-71.
6. Hopman EH, Kenemans P, Helmerhorst ThJM. Positive predictive rate of colposcopic examination of the cervix uteri: an overview of literature. Obstet Gynecol Surv 1998;53:97-106.
7. Schneider A, Hoyer H, Lotz B, Leistritza S, Kühne-Heid R, Nindl I, et al. Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy. Int J Cancer 2000;89:529-34.
8. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. ALTS Study group. J Natl Cancer Inst 2001;93:293-9.
9. Sherman ME, Schiffman M, Cox JT. Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS). J Natl Cancer Inst 2002;94:102-7.
10. Helmerhorst ThJM, Wijnen JA. Richtlijnen bevolkingsonderzoek baarmoederhalskanker. Ned Tijdschr Obstet Gynaecol 1998;111: 264-5.
11. Melchers WJ, Bakkers JM, Wang J, Wilde PCM de, Boonstra H, Quint WGV, et al. Short fragment polymerase chain reaction reverse hybridization line probe assay to detect and genotype a broad spectrum of human papillomavirus types. Clinical evaluation and follow-up. Am J Pathol 1999;155:1473-8.
12. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-65.
13. Woodman CB, Collins S, Winter H, Bailey A, Ellis J, Prior P, et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 2001;357:1831-6.
14. Giard RWM, Coebergh JWW. Bevolkingsonderzoek op baarmoederhalskanker: eventuele winst niet bij voorbaat groter door diagnostiek op humaan papillomavirus. Ned Tijdschr Geneeskd 2000; 144:1664-8.
15. Herbst AL, Pickett KE, Follen M, Noller KL. The management of ASCUS cervical cytologic abnormalities and HPV testing: a cautionary note. Obstet Gynecol 2001;98(5 Pt 1):849-51.
16. Nobbenhuis MA, Walboomers JM, Helmerhorst ThJM, Rozendaal L, Remmink AJ, Risse EK, et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 1999;354:20-5.
17. Lytwyn A, Sellors JW, Mahony JB, Daya D, Chapman W, Ellis N, et al. Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities: a randomized trial. HPV Effectiveness in Lowgrade Paps (HELP) Study No. 1 Group. CMAJ 2000;163:701-7.